John Mulcahy is the founder of SiteOne Therapeutics. SiteOne Therapeutics has raised $100M in total funding. Latest round: Series C.
John Mulcahy is a co-founder, President, and Chief Executive Officer at SiteOne Therapeutics, a clinical-stage biopharmaceutical company. The company focuses on developing non-opioid therapeutics for pain and sensory hyperexcitability disorders by advancing selective ion channel modulators.
Full founder directory · Investor directory · Company funding database · Fundraising library